We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysis.
- Authors
Hillner, B E; Weeks, J C; Desch, C E; Smith, T J
- Abstract
Pamidronate is effective in reducing bony complications in patients with metastatic breast cancer who have known osteolytic lesions. However, pamidronate does not increase survival and is associated with additional financial costs and inconvenience. We conducted a post-hoc evaluation of the cost-effectiveness of pamidronate using the results of two randomized trials that evaluated pamidronate 90 mg administered intravenously every month versus placebo.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Vol 18, Issue 1, p72
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2000.18.1.72